Your Digital Pathology Partners
OracleBio supports Pharmaceutical R&D with detailed quantification of histopathology images: from fast and efficient single Chromogenic Immunohistochemistry (IHC) to comprehensive Multiplex Immunofluorescence (mIF) analysis.
We’re harnessing cutting-edge technology such as AI Deep Learning and Cloud Computing to transform preclinical and clinical research.
Latest Blogs & Insights
Accessing Expertise in Quantitative Digital Pathology: OracleBio’s Innovative FTE Service
⚡ Article Synopsis: In this article, OracleBio’s Senior Business Development Manager, Keith Bowers, explains our new contracting model to supply trained image analysis resource to the computational pathology departments of Pharma and Biotech. The benefits of this...
2023 Wrapped: OracleBio’s Year in Review
⚡ Article Synopsis: In this article, Senior Marketing Manager, Mark Laurie, wraps up OracleBio's highlights and achievement of 2023, and gives you a glimpse of what's to come in 2024.As 2023 draws to a close, and as is our annual OracleBio tradition, we reflect on...
AI-augmented and Pathologist-guided quantification of morphologically distinct cells in tumor tissue
⚡ Article Synopsis: In this article, OracleBio Senior Clinical Pathologist, Dr. James Going, provides an overview of how cell counting methods in cancer research have evolved. James focuses on a recent project that uses AI to improve the accuracy of macrophage...
Case Studies
Liver Fibrosis & Steatosis Analysis
. Note: Permission has been granted for the use of this materialStudy BackgroundThis study's aim was to develop a method of analysis that would measure both the PSR collagen staining and the white space of the fatty vacuoles, steatosis without contamination of the...
Advanced Liver Fibrosis Analysis
. Note: Permission has been granted for the use of this materialStudy BackgroundThis study's aim was to make robust measurements of collagen and αSMA staining within the livers of mice from a bile-duct ligation model, by factoring out the varying and confounding...
Assessment of Lung Fibrosis by Image Analysis
. Note: Permission has been granted for the use of this materialStudy BackgroundThis study's aim was to make robust measurements of collagen and cell number in lesional areas of fibrotic lung from mouse Bleomycin model.Sample DetailsMouse Bleomycin...
Scientific Posters
Accurate Segmentation of Distinct Cell Populations in using AI Deep Learning to Optimise Quantitative Digital Pathology Workflows
ℹ️ Click the thumbnail image above to view or download the high-resolution poster PDF.This poster was presented at the 10th Digital Pathology & AI Congress Europe, London 2023. The poster covers: Accurate identification and quantification of diverse cell...
The Development and Application of an Ultrahigh-Plex Antibody Panel for Spatial Phenotyping of Mouse Brain Tissues in Homeostatic and Diseased States
ℹ️ Click the thumbnail image above to view or download the high-resolution poster PDF.This poster was presented at SfN 2023, Washington, and created in collaboration with Akoya Biosciences. OracleBio performed image quality control (QC), annotation of the region of...
Ultrahigh-plex to High-throughput Spatial Phenotyping: An Integrated Pathway from Discovery to Translational and Clinical Studies
ℹ️ Click the thumbnail image above to view or download the high-resolution poster PDF.This poster is presented at SITC 2023 San Diego & the 10th Digital Pathology & AI Congress Europe, and created in collaboration with Akoya Biosciences. Objective: The study...
Webinars
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cancer Immunotherapy
⚡ Webinar Synopsis: In this webinar, OracleBio Chief Scientific Officer, Lorcan Sherry, and Akoya Bioscience Senior Data Scientist, Aditya Pratapa, PhD, present a new workflow for analyzing multiplex immunofluorescence images. About this Webinar: Spatial Signatures...
Living in a Spatial World: Characterizing the Immune Environment in Tumors
About this Webinar: Immunotherapy has transformed the treatment of metastatic and recurrent solid tumors. Advances in technology in the past few years have created unprecedented opportunities to better identify biomarkers of disease processes, especially by using...
Using Artificial Intelligence to support Quantitative Digital Pathology in R&D
About this Webinar: This session, 'Using Artificial Intelligence (AI) to support Quantitative Digital Pathology in R&D', was live on Wednesday 17th November 2021. You can re-watch the full webinar including the Q&A above. Presented by OracleBio's Chief...
Why OracleBio?
We are a specialised CRO, with years of experience delivering high quality data for small, medium and large Pharma.
Highly skilled in quantitative digital pathology, we’re able to expertly address complex image analysis studies.
OracleBio is a registered provider on Scientist.com & Science Exchange.
GCP Services
Our Good Clinical Practice (GCP) service offering generates quantitative image analysis data using a workflow that is conducted in accordance with GCP principles.
This provides our clients with quality assured data which can be included in a data package for submission to regulatory authorities.
Our Expertise
We provide high precision, quantitative digital pathology services to support pre-clinical and clinical research. Delivering accurate and detailed quantification of nuclear, membrane and cytoplasmic markers on a cell-by-cell basis within Histology, IHC and ISH tissue sections.